⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LNTH News
Lantheus Holdings, Inc
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
globenewswire.com
LNTH
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
globenewswire.com
LNTH
Form 8-K
sec.gov
LNTH
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
LNTH
Lantheus to Present at March 2026 Investor Conferences
globenewswire.com
LNTH
Bronstein, Gewirtz & Grossman, LLC Encourages Lantheus Holdings, Inc. (LNTH) Shareholders to Inquire about Securities Investigation
accessnewswire.com
LNTH
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Shareholders to Connect
accessnewswire.com
LNTH
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Shareholders to Reach Out
accessnewswire.com
LNTH
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
prnewswire.com
LNTH
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
LNTH